Centro Cardiologico Monzino

EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation

No phase, Active, not recruiting, 2026, 300 people, 5 Oct 2026, clinicaltrials.gov

NCT06922994

Phase 2, Recruiting, 2025, 102 people, 11 Apr 2025, clinicaltrials.gov

NCT04303377

Collaborator, Phase 2, Withdrawn, 2019, 0 people, 11 Mar 2020, clinicaltrials.gov

NCT04154982

Phase 2, Completed, 2020, 181 people, 7 Nov 2019, clinicaltrials.gov

NCT01466452

Phase 2, Status unknown, 2011, 99 people, 8 Nov 2011, clinicaltrials.gov

European Commission

HORIZON-JU-RIA, EXIT-CVD, 101253160, €726.2k, 2026–2031, 31 Mar 2026, cordis.europa.eu

Sirtuin 1 modulation unlocks the therapeutic potential of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in calcific aortic valve stenosis

8 Sept 2026, api.crossref.org